Contributor
David Balto argues in Modern Healthcare that a number of provisions in the recently passed health care bill will promote competition as long as they are enforced.
David Balto discusses in The Hill that the Federal Trade Commission should receive a full range of powers to effectively protect consumers from deceptive and fraudulent conduct.
The FTC has the opportunity to open up the microprocessor market to new competition and innovation in its case against Intel, explains David Balto in a Huffington Post column.
The Federal Trade Commission has a straightforward antitrust case against Intel, says David Balto.
David Balto stresses the importance of health care reform after analyzing the anticompetitive practices of Pennsylvania's four largest insurers.
While transparency may be an annoyance for the PBMs, it will enhance the federal government’s ability to hold them accountable and reduce waste in prescription drug spending, writes David Balto.
![Assistant Attorney General Christine Varney, pictured above, has noted, “the most egregiously anticompetitive claims, such as naked agreements fixing price or reducing coverage, are virtually always found immune [under the exemption].” (CAP)](https://www.americanprogress.org/wp-content/uploads/2010/02/varney_onpage.jpg?w=450)
David Balto explains the basics of how and why we need to reform health care antitrust laws.
David Balto comments at Billboard on the merger between Ticketmaster and Live Nation, which was approved by the Justice Department in January.
Eliminating the antitrust exemption is an important first step to allowing the lodestar of competition to guide health insurance markets, writes David Balto.
Congress is preparing to finalize a health care bill for both chambers to consider. The purpose of healthcare reform is to increase the number of insured, improve the level of health care and reduce health care spending. Although there are many disputes in the health care debate, two issues seem clear. First, integrated health care systems, which combine payment and health care delivery, are superior in delivering high quality health care and controlling health care costs. Second, traditional health insurers that focus solely on payment dominate health insurance markets, resulting in escalating costs, higher premiums and the chronic problems of the uninsured.
Antitrust enforcement is the bulwark to a competitive market. Unfortunately, over the past several years, there has been very little merger enforcement exerted by the Department of Justice. In fact, the DOJ has not tried a merger case for over five years.